JETREA

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	24856-002		D	Discontinued by firm		2026-07-31
excluded package	package	24856-002	24856-002-01	D	Discontinued by firm		2026-07-31

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
24856-002-01	ML - Milliliter	24856-002	e1edc360-f95a-4b95-90cd-c3ae326248cd	1	2017-10-13

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125422	Jetrea	ocriplasmin	351(a)	Disc	2026-06-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7V6HE3DM5A	OCRIPLASMIN	1048016-09-6	OCRIPLASMIN

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
JETREA	ThromboGenics Inc. \| Patheon UK Limited \| Patheon Italia S.P.A \| Fujifilm Diosynth Biotechnologies UK	2020-06-12	HUMAN PRESCRIPTION DRUG LABEL	4